Article Details
Retrieved on: 2020-12-02 17:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... Commission has approved obiltoxaximab, the company's <b>monoclonal antibody</b> (mAb) anthrax antitoxin for the treatment of inhalation anthrax.
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here